1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273.e1. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Gao J, Xie L, Yang WS, Zhang W, Gao S,
Wang J and Xiang YB: Risk factors of hepatocellular carcinoma -
current status and perspectives. Asian Pac J Cancer Prev.
13:743–752. 2012. View Article : Google Scholar
|
5
|
Portolani N, Coniglio A, Ghidoni S,
Giovanelli M, Benetti A, Tiberio GA and Giulini SM: Early and late
recurrence after liver resection for hepatocellular carcinoma:
Prognostic and therapeutic implications. Ann Surg. 243:229–235.
2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gramantieri L, Ferracin M, Fornari F,
Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E,
Grazi GL, et al: Cyclin G1 is a target of miR-122a, a microRNA
frequently down-regulated in human hepatocellular carcinoma. Cancer
Res. 67:6092–6099. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Budhu A, Jia HL, Forgues M, Liu CG,
Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, et al:
Identification of metastasis-related microRNAs in hepatocellular
carcinoma. Hepatology. 47:897–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
8
|
Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP and
Zhuang SM: MicroRNA-195 suppresses tumorigenicity and regulates
G1/S transition of human hepatocellular carcinoma cells.
Hepatology. 50:113–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
9
|
Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y
and Zhuang SM: MicroRNA-101, down-regulated in hepatocellular
carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer
Res. 69:1135–1142. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Murakami Y, Yasuda T, Saigo K, Urashima T,
Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of
microRNA expression patterns in hepatocellular carcinoma and
non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar
|
11
|
Braconi C and Patel T: MicroRNA expression
profiling: A molecular tool for defining the phenotype of
hepatocellular tumors. Hepatology. 47:1807–1809. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Murakami Y, Tamori A, Itami S, Tanahashi
T, Toyoda H, Tanaka M, Wu W, Brojigin N, Kaneoka Y, Maeda A, et al:
The expression level of miR-18b in hepatocellular carcinoma is
associated with the grade of malignancy and prognosis. BMC Cancer.
13:992013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Gramantieri L, Fornari F, Callegari E,
Sabbioni S, Lanza G, Croce CM, Bolondi L and Negrini M: MicroRNA
involvement in hepatocellular carcinoma. J Cell Mol Med.
12:2189–2204. 2008. View Article : Google Scholar
|
14
|
Wang B, Majumder S, Nuovo G, Kutay H,
Volinia S, Patel T, Schmittgen TD, Croce C, Ghoshal K and Jacob ST:
Role of microRNA-155 at early stages of hepatocarcinogenesis
induced by choline-deficient and amino acid-defined diet in C57BL/6
mice. Hepatology. 50:1152–1161. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Coulouarn C, Factor VM, Andersen JB,
Durkin ME and Thorgeirsson SS: Loss of miR-122 expression in liver
cancer correlates with suppression of the hepatic phenotype and
gain of metastatic properties. Oncogene. 28:3526–3536. 2009.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Ji J, Shi J, Budhu A, Yu Z, Forgues M,
Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, et al: MicroRNA
expression, survival, and response to interferon in liver cancer. N
Engl J Med. 361:1437–1447. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ji J, Yamashita T, Budhu A, Forgues M, Jia
HL, Li C, Deng C, Wauthier E, Reid LM, Ye QH, et al: Identification
of microRNA-181 by genome-wide screening as a critical player in
EpCAM-positive hepatic cancer stem cells. Hepatology. 50:472–480.
2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ladeiro Y, Couchy G, Balabaud C,
Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Song G, Sharma AD, Roll GR, Ng R, Lee AY,
Blelloch RH, Frandsen NM and Willenbring H: MicroRNAs control
hepatocyte proliferation during liver regeneration. Hepatology.
51:1735–1743. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Ura S, Honda M, Yamashita T, Ueda T,
Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K and Kaneko
S: Differential microRNA expression between hepatitis B and
hepatitis C leading disease progression to hepatocellular
carcinoma. Hepatology. 49:1098–1112. 2009. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang Y, Lee AT, Ma JZ, Wang J, Ren J, Yang
Y, Tantoso E, Li KB, Ooi LL, Tan P, et al: Profiling microRNA
expression in hepatocellular carcinoma reveals microRNA-224
up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific
target. J Biol Chem. 283:13205–13215. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Yuan B, Liang Y, Wang D and Luo F: miR-940
inhibits hepatocellular carcinoma growth and correlates with
prognosis of hepatocellular carcinoma patients. Cancer Sci.
106:819–824. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Li D, Liu X, Lin L, Hou J, Li N, Wang C,
Wang P, Zhang Q, Zhang P, Zhou W, et al: MicroRNA-99a inhibits
hepatocellular carcinoma growth and correlates with prognosis of
patients with hepatocellular carcinoma. J Biol Chem.
286:36677–36685. 2011. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wu N, Zhang C, Bai C, Han YP and Li Q:
miR-4782-3p inhibited non-small cell lung cancer growth via USP14.
Cell Physiol Biochem. 33:457–467. 2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Huang G, Li L and Zhou W: USP14 activation
promotes tumor progression in hepatocellular carcinoma. Oncol Rep.
34:2917–2924. 2015.PubMed/NCBI
|
27
|
Song B, Zhang C, Li G, Jin G and Liu C:
miR-940 inhibited pancreatic ductal adenocarcinoma growth by
targeting MyD88. Cell Physiol Biochem. 35:1167–1177. 2015.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Liu C, Gao F, Li B, Mitchel RE, Liu X, Lin
J, Zhao L and Cai J: TLR4 knockout protects mice from
radiation-induced thymic lymphoma by downregulation of IL6 and
miR-21. Leukemia. 25:1516–1519. 2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Liu C, Zhou C, Gao F, Cai S, Zhang C, Zhao
L, Zhao F, Cao F, Lin J, Yang Y, et al: miR-34a in age and tissue
related radio-sensitivity and serum miR-34a as a novel indicator of
radiation injury. Int J Biol Sci. 7:221–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Lin L, Liang H, Wang Y, Yin X, Hu Y, Huang
J, Ren T, Xu H, Zheng L and Chen X: microRNA-141 inhibits cell
proliferation and invasion and promotes apoptosis by targeting
hepatocyte nuclear factor-3β in hepatocellular carcinoma cells. BMC
Cancer. 14:8792014. View Article : Google Scholar
|
31
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
32
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar :
|
33
|
Grimson A, Farh KK, Johnston WK,
Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting
specificity in mammals: Determinants beyond seed pairing. Mol Cell.
27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
34
|
Garcia DM, Baek D, Shin C, Bell GW,
Grimson A and Bartel DP: Weak seed-pairing stability and high
target-site abundance decrease the proficiency of lsy-6 and other
microRNAs. Nat Struct Mol Biol. 18:1139–1146. 2011. View Article : Google Scholar : PubMed/NCBI
|
35
|
Grentzmann G, Ingram JA, Kelly PJ,
Gesteland RF and Atkins JF: A dual-luciferase reporter system for
studying recoding signals. RNA. 4:479–486. 1998.PubMed/NCBI
|
36
|
Wu N, Liu C, Bai C, Han YP, Cho WC and Li
Q: Over-expression of deubiquitinating enzyme USP14 in lung
adenocarcinoma promotes proliferation through the accumulation of
β-catenin. Int J Mol Sci. 14:10749–10760. 2013. View Article : Google Scholar : PubMed/NCBI
|
37
|
Wang Y, Wang J, Zhong J, Deng Y, Xi Q, He
S, Yang S, Jiang L, Huang M, Tang C, et al: Ubiquitin-specific
protease 14 (USP14) regulates cellular proliferation and apoptosis
in epithelial ovarian cancer. Med Oncol. 32:3792015. View Article : Google Scholar
|